Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Lobelia Inflata Whole is a botanical substance primarily utilized in non-standardized plant allergenic extracts and historically for respiratory conditions. It contains the alkaloid lobeline, which functions as a cholinergic nicotinic agonist, though its clinical use is strictly regulated.
Name
Lobelia Inflata Whole
Raw Name
LOBELIA INFLATA WHOLE
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
33
Variant Count
35
Last Verified
February 17, 2026
About Lobelia Inflata Whole
Lobelia Inflata Whole is a botanical substance primarily utilized in non-standardized plant allergenic extracts and historically for respiratory conditions. It contains the alkaloid lobeline, which functions as a cholinergic nicotinic agonist, though its clinical use is strictly regulated.
Detailed information about Lobelia Inflata Whole
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Lobelia Inflata Whole.
Lobelia Inflata Whole refers to the entire plant of Lobelia inflata, a species native to North America often colloquially known as 'Indian Tobacco' or 'Puke Weed.' In contemporary clinical practice, Lobelia Inflata Whole belongs to a class of drugs called Non-Standardized Plant Allergenic Extracts [EPC]. While historically utilized in traditional medicine for various respiratory ailments, its modern pharmaceutical application is primarily focused on diagnostic and therapeutic allergenic protocols. It is also classified under broader categories such as Cholinergic Nicotinic Agonists [EPC] due to the presence of the alkaloid lobeline.
The FDA has a complex history with Lobelia inflata. While it was once a common ingredient in over-the-counter (OTC) smoking cessation products, the FDA issued a ruling in 1993 stating that lobeline preparations were not generally recognized as safe and effective (GRASE) for smoking cessation. Consequently, its use in that specific context was curtailed in the United States. However, the whole plant extract remains available in non-standardized forms for allergenic testing and within the Homeopathic Pharmacopoeia of the United States (HPUS). Healthcare providers typically utilize these extracts to identify specific plant sensitivities in patients undergoing allergy evaluations.
The primary active constituent of Lobelia Inflata Whole is lobeline, a piperidine alkaloid. At the molecular level, lobeline acts as a partial agonist at nicotinic acetylcholine receptors (nAChRs). It exhibits a high affinity for the α4β2 receptor subtype, which is the same site targeted by nicotine. By binding to these receptors, lobeline can mimic some of the physiological effects of nicotine, albeit with significantly lower potency and different downstream signaling pathways. This mechanism is why it was historically explored for tobacco cessation; it was intended to satisfy the craving for nicotine without providing the same level of reinforcement.
Furthermore, Lobelia Inflata Whole exerts effects on the central nervous system through the modulation of dopamine. Research suggests that lobeline interacts with the vesicular monoamine transporter 2 (VMAT2). By inhibiting VMAT2, lobeline alters the storage and release of dopamine within the synaptic cleft. This complex interaction with the dopaminergic system provides the pharmacological basis for its historical use in treating various neurological and respiratory conditions, although modern clinical evidence for these uses is limited. In the context of an allergenic extract, the mechanism is immunological, where the plant's proteins trigger an IgE-mediated response in sensitized individuals during skin prick testing.
> Important: Only your healthcare provider can determine if Lobelia Inflata Whole is right for your specific condition. The use of this substance must be closely monitored due to its narrow therapeutic index and potential for toxicity.
Standard dosing for Lobelia Inflata Whole is not well-established for systemic use due to its potential toxicity. When used as an allergenic extract, the dosage is determined by the concentration of the extract (e.g., 1:10 or 1:20 w/v) and the specific protocol of the allergist. For skin prick testing, a single drop of the extract is usually applied to the skin, followed by a puncture. For therapeutic allergy desensitization (immunotherapy), doses start extremely low and are gradually increased based on patient tolerance and the absence of systemic reactions.
In traditional or alternative contexts, doses of the tincture (1:10) were historically cited as 0.6 to 2.0 mL, but modern clinical guidelines strongly advise against these doses due to the risk of severe emesis and respiratory depression. Always consult a healthcare provider before any form of ingestion.
Lobelia Inflata Whole is generally NOT approved for pediatric use in conventional medicine, except under the strict supervision of a pediatric allergist for diagnostic purposes. The alkaloids in Lobelia are highly toxic to children, and even small amounts can lead to severe poisoning. Pediatric patients are more susceptible to the respiratory and cardiovascular effects of lobeline.
There are no specific dosing guidelines for patients with renal impairment. However, since the metabolites of lobeline are excreted renally, caution is advised. Reduced clearance may lead to an accumulation of alkaloids, increasing the risk of toxicity.
Because Lobelia alkaloids undergo significant hepatic metabolism, patients with liver disease (e.g., cirrhosis or hepatitis) should avoid this substance. Impaired liver function can lead to dangerously high systemic levels of lobeline.
Geriatric patients should be treated with extreme caution. The elderly are more likely to have underlying cardiovascular conditions that could be exacerbated by the nicotinic and adrenergic effects of the plant's constituents.
If prescribed an allergenic extract for immunotherapy:
If using homeopathic forms:
In the context of allergy immunotherapy, a missed dose can disrupt the desensitization process. Contact your allergist immediately. Do not double the next dose to catch up, as this significantly increases the risk of a systemic allergic reaction.
Signs of Lobelia overdose (lobeline toxicity) include:
In case of suspected overdose, contact emergency services or a poison control center immediately. Treatment is primarily supportive, focusing on maintaining airway patency and cardiovascular stability.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to self-medicate with Lobelia Inflata Whole without medical guidance.
The most common side effect of Lobelia Inflata Whole is gastrointestinal distress. Because of its nickname 'Puke Weed,' it is no surprise that nausea and vomiting are extremely frequent. These symptoms often occur shortly after ingestion and are a result of the plant's direct irritation of the gastric mucosa and its effect on the chemoreceptor trigger zone in the brain. Other common effects include:
> Warning: Stop taking Lobelia Inflata Whole and call your doctor immediately if you experience any of these serious symptoms.
There is limited clinical data on the long-term use of Lobelia Inflata Whole. However, chronic exposure to lobeline may lead to persistent cardiovascular strain and potential changes in nicotinic receptor sensitivity. Prolonged use of emetic-inducing substances can also lead to electrolyte imbalances (such as hypokalemia) and damage to the esophagus or tooth enamel due to frequent vomiting.
No FDA black box warnings are currently issued specifically for Lobelia Inflata Whole as a plant extract. However, it is important to note that the FDA has removed it from the list of approved smoking cessation aids due to safety concerns. In the context of allergenic extracts, there is a general class warning regarding the risk of severe systemic reactions, including anaphylaxis, which must be managed in a clinical setting equipped with emergency resuscitation equipment.
Report any unusual symptoms to your healthcare provider. Early intervention is critical in managing botanical toxicity or allergic reactions.
Lobelia Inflata Whole contains potent alkaloids that have a very narrow therapeutic window, meaning the difference between a 'therapeutic' dose and a toxic dose is very small. It should never be used as a substitute for conventional medical treatments for asthma or smoking cessation. Patients with pre-existing heart disease, high blood pressure, or respiratory disorders must exercise extreme caution, as the nicotinic effects of the plant can exacerbate these conditions.
No FDA black box warnings for Lobelia Inflata Whole are currently active. However, healthcare providers must adhere to the general warnings associated with allergenic extracts, which emphasize that these products can cause life-threatening anaphylaxis even in individuals who have previously tolerated them.
Patients undergoing treatment or testing with Lobelia Inflata Whole should have the following monitored:
Lobelia can cause dizziness, tremors, and blurred vision. Patients should not drive or operate heavy machinery until they are certain how the substance affects them. If any neurological symptoms occur, these activities should be avoided entirely.
Alcohol should be strictly avoided when using Lobelia. Alcohol can potentiate the sedative and nauseating effects of the plant's alkaloids, increasing the risk of severe vomiting and respiratory depression.
There is no documented 'withdrawal syndrome' for Lobelia Inflata Whole; however, if it is being used in a homeopathic or alternative context, it should be tapered under the guidance of a professional to monitor for the return of original symptoms. In immunotherapy, discontinuation must be managed by an allergist to determine the appropriate restart protocol.
> Important: Discuss all your medical conditions with your healthcare provider before starting Lobelia Inflata Whole.
For each major interaction, the primary mechanism is usually pharmacodynamic (acting on the same receptors) or physiological (opposing effects on the cardiovascular system). The clinical consequence is typically an increase in cardiovascular or neurological toxicity. Management involves avoiding the combination or rigorous monitoring of vital signs.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Lobelia Inflata Whole must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients who are allergic to other plants in the Lobelia genus (such as Lobelia siphilitica) are highly likely to react to Lobelia Inflata Whole. There may also be cross-reactivity with certain other botanical extracts used in allergenic panels; however, specific cross-reactive proteins have not been fully mapped.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing or administering Lobelia Inflata Whole.
Lobelia Inflata Whole is classified as unsafe for use during pregnancy. There is no formal FDA pregnancy category (A, B, C, D, X) assigned to the whole plant extract, but it is traditionally recognized as an abortifacient. The alkaloid lobeline can cross the placenta and may interfere with fetal nicotinic receptor development, which is crucial for brain and lung maturation. Use during any trimester carries the risk of uterine stimulation and fetal toxicity.
It is unknown if Lobelia alkaloids pass into human breast milk. However, due to the low molecular weight and lipophilic nature of lobeline, it is highly probable that it is excreted in milk. Given the extreme sensitivity of infants to nicotinic agonists, breastfeeding is not recommended while using any form of Lobelia. Potential risks to the nursing infant include vomiting, tremors, and respiratory distress.
Lobelia is not approved for use in children. Historical use in pediatric respiratory conditions has been linked to numerous cases of poisoning. Children have a smaller volume of distribution and immature metabolic pathways, making them significantly more vulnerable to the toxic effects of lobeline. In the case of accidental ingestion by a child, seek emergency medical care immediately.
In elderly patients, the use of Lobelia Inflata Whole is associated with a higher risk of adverse cardiovascular events. Age-related declines in renal and hepatic function mean that the alkaloids may stay in the system longer. Furthermore, the risk of falls due to dizziness or hypotension (following initial hypertension) is a major concern in this population. Polypharmacy in the elderly also increases the likelihood of dangerous drug interactions.
Patients with a GFR (Glomerular Filtration Rate) below 60 mL/min/1.73m² should use Lobelia with extreme caution. While specific dose-adjustment tables do not exist, healthcare providers typically reduce the frequency of administration or avoid the substance entirely in cases of stage 4 or 5 chronic kidney disease.
For patients with Child-Pugh Class B or C hepatic impairment, Lobelia Inflata Whole is generally contraindicated. The liver's inability to process lobeline can lead to rapid accumulation and acute toxicity, manifesting as severe emesis and neurological depression.
> Important: Special populations require individualized medical assessment. Never administer Lobelia to a member of a sensitive population without direct medical supervision.
Lobelia Inflata Whole acts primarily through its constituent alkaloid, lobeline. Lobeline is a potent ligand for nicotinic acetylcholine receptors (nAChRs). It acts as a mixed agonist-antagonist (partial agonist). Specifically, it binds to the α4β2 receptor subtype in the central nervous system, which modulates the release of various neurotransmitters. Unlike nicotine, lobeline does not produce the same level of synaptic dopamine surge, which is why it was studied as a non-addictive alternative for smoking cessation.
Additionally, lobeline is a potent inhibitor of the vesicular monoamine transporter 2 (VMAT2). By binding to VMAT2, it prevents the storage of dopamine into synaptic vesicles, thereby increasing the cytosolic concentration of dopamine and altering the overall dopaminergic tone. This dual action on nAChRs and VMAT2 distinguishes Lobelia from other nicotinic agents.
The dose-response relationship of Lobelia is notoriously steep. Small doses may act as a respiratory stimulant by irritating the carotid body chemoreceptors, which reflexively increases the rate and depth of breathing. However, as the dose increases, the effect quickly shifts to respiratory depression. The duration of effect is short, typically lasting 1 to 3 hours. Tolerance to the emetic effects can develop with repeated exposure, but the cardiovascular risks remain constant.
| Parameter | Value |
|---|---|
| Bioavailability | 5-20% (Oral due to first-pass) |
| Protein Binding | Not extensively documented |
| Half-life | 1.0 - 2.0 hours |
| Tmax | 0.5 - 1.0 hours |
| Metabolism | Hepatic (CYP450 system) |
| Excretion | Renal 80-90%, Fecal <10% |
Lobelia Inflata Whole is classified as a Non-Standardized Plant Allergenic Extract [EPC]. Within the realm of pharmacology, it is also categorized as a Cholinergic Nicotinic Agonist. It shares some functional similarities with nicotine and varenicline but possesses a distinct botanical and toxicological profile.
Common questions about Lobelia Inflata Whole
Lobelia Inflata Whole is primarily used today as a non-standardized plant allergenic extract for diagnostic allergy testing. Healthcare providers use it to determine if a patient has a specific sensitivity to the Lobelia plant through skin prick or intradermal tests. Historically, it was used in traditional medicine for respiratory issues like asthma and as an aid for smoking cessation, though these uses are no longer FDA-approved. It also appears in very dilute concentrations within homeopathic medicine for various ailments. You should only use Lobelia products under the strict guidance of a qualified medical professional.
The most frequent side effects of Lobelia Inflata Whole are gastrointestinal in nature, specifically severe nausea and vomiting. This occurs because the plant contains alkaloids that irritate the stomach lining and signal the brain's vomiting center. Other common side effects include dizziness, profuse sweating, and increased salivation. Some patients may also experience a rapid heartbeat or tremors shortly after exposure. Because of these potent effects, the plant earned the nickname 'Puke Weed' in historical medical texts.
No, you should not drink alcohol while taking or being treated with Lobelia Inflata Whole. Alcohol can significantly increase the sedative effects of the plant's alkaloids and may worsen gastrointestinal distress, leading to dangerous bouts of vomiting. Furthermore, both alcohol and Lobelia can affect your central nervous system, and combining them increases the risk of respiratory depression and coordination loss. Always inform your doctor about your alcohol consumption habits before starting any new treatment involving botanical extracts. Safety is the priority when dealing with substances that have a narrow therapeutic range.
Lobelia Inflata Whole is considered unsafe during pregnancy and should be strictly avoided. It is known as an emmenagogue, meaning it can stimulate blood flow in the pelvic area and induce uterine contractions, which may lead to miscarriage or preterm labor. The active alkaloid, lobeline, can also cross the placenta and potentially interfere with the development of the fetus's nervous system. There is insufficient data to guarantee safety at any stage of pregnancy. If you are pregnant or planning to become pregnant, discuss safer alternatives with your healthcare provider immediately.
The onset of action for Lobelia Inflata Whole is relatively rapid, especially when the alkaloids are absorbed through the mucous membranes or injected as an extract. For allergenic skin testing, a reaction (like a hive or redness) typically appears within 15 to 20 minutes. If taken orally in traditional forms, gastrointestinal effects like nausea can begin within 30 minutes. The systemic effects on the respiratory and cardiovascular systems also manifest quickly but tend to wear off within a few hours due to the short half-life of lobeline. However, the duration of effect can vary based on the individual's metabolism and the dose administered.
If you are using Lobelia in a clinical setting for allergy immunotherapy, you should not stop the treatment without consulting your allergist, as this can interfere with the desensitization process. For those using it in alternative or homeopathic forms, sudden discontinuation is generally not associated with physical withdrawal symptoms like those seen with nicotine. However, the original symptoms you were treating may return or worsen. Always seek medical advice before stopping any prescribed or supplemental regimen. Your doctor will help you determine if a tapering schedule is necessary for your specific situation.
If you miss a scheduled dose of a Lobelia-based allergenic extract, contact your healthcare provider or allergy clinic immediately for instructions. Do not attempt to 'double up' on the next dose, as this significantly increases the risk of a severe systemic allergic reaction or toxicity. In the context of homeopathic use, simply take the next dose at your regularly scheduled time. Consistency is important for the efficacy of allergy treatments, so your provider may need to adjust your schedule if multiple doses are missed. Always follow the specific protocol provided by your medical team.
There is no clinical evidence to suggest that Lobelia Inflata Whole causes weight gain. In fact, because its primary side effects include nausea and vomiting, it is more likely to cause a temporary decrease in appetite or weight loss if used inappropriately. Historically, some people mistakenly thought it might help with weight management due to its stimulant-like effects, but this is not a medically recognized use. If you experience unexpected weight changes while using Lobelia, you should discuss this with your doctor. It is important to focus on evidence-based methods for weight management rather than potentially toxic botanical extracts.
Lobelia Inflata Whole has several significant drug interactions and should be used with extreme caution if you are taking other medications. It is particularly dangerous when combined with nicotine replacement therapies, as it can lead to nicotine toxicity. It may also interact with blood pressure medications, antidepressants (especially MAOIs), and other stimulants. Because it affects the heart and central nervous system, the risk of adverse reactions is high when multiple drugs are involved. Always provide your healthcare provider with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are currently taking.
Lobelia Inflata Whole is a natural botanical substance, so the term 'generic' does not apply in the same way it does to synthetic drugs. However, it is available from various manufacturers as a non-standardized extract, tincture, or homeopathic preparation. These products are not interchangeable, as the concentration of active alkaloids can vary significantly between brands and batches. In the United States, allergenic extracts are regulated by the FDA, but other forms may be sold as dietary supplements with less rigorous oversight. Always ensure you are using a high-quality product from a reputable source recommended by your doctor.